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DietThere is mounting evidence that noncoding microRNAs (miRNA) are modulated by select chemoprotective die-
tary agents. For example, recently we demonstrated that the unique combination of dietary ﬁsh oil (containing
n − 3 fatty acids) plus pectin (fermented to butyrate in the colon) (FPA) up-regulates a subset of putative
tumor suppressor miRNAs in intestinal mucosa, and down-regulates their predicted target genes following car-
cinogen exposure as compared to control (corn oil plus cellulose (CCA)) diet. To further elucidate the biological
effects of diet and carcinogenmodulatedmiR's in the colon, we veriﬁed thatmiR-26b andmiR-203 directly target
PDE4B and TCF4, respectively. Since perturbations in adult stem cell dynamics are generally believed to represent
an early step in colon tumorigenesis and to better understand how the colonic stem cell population responds to
environmental factors such as diet and carcinogen, we additionally determined the effects of the
chemoprotective FPA diet on miRNAs and mRNAs in colonic stem cells obtained from Lgr5-EGFP-IRES-creERT2
knock-in mice. Following global miRNA proﬁling, 26 miRNAs (P b 0.05) were differentially expressed in Lgr5high
stem cells as compared to Lgr5negative differentiated cells. FPA treatment up-regulated miR-19b, miR-26b and
miR-203 expression as compared to CCA speciﬁcally in Lgr5high cells. In contrast, in Lgr5negative cells, only miR-
19b and its indirect target PTK2Bweremodulated by the FPA diet. These data indicate for the ﬁrst time that select
dietary cues can impact stem cell regulatory networks, in part, by modulating the steady-state levels of miRNAs.
To our knowledge, this is the ﬁrst study to utilize Lgr5+ reportermice to determine the impact of diet and carcin-
ogen on miRNA expression in colonic stem cells and their progeny.
© Elsevier B.V. All rights reserved.20151. Introduction
miRNAs are a class of noncoding RNAs involved in the regulation of
several key cellular processes such as signal transduction, apoptosis, cell
proliferation, morphogenesis and the pathogenesis of cancer [1,2].
Structurally, these are 19–24 nucleotide RNAs which are ﬁrst tran-
scribed as long primary miRNAs, and then processed into 60–70 nt
miRNA precursors (pre-miRNA) by nuclear RNAse III Drosha and its
partner proteins. The pre-miRNA complex is subsequently transported
to the cytoplasm where it is further processed by Dicer into a miRNAnvironmental Health Research,duplex, taken up by the RISC complex, which can bind to complementa-
ry sequences at the 3′ untranslated region (UTR) of target mRNA. This
results in the blockade of mRNA translation and/or induces mRNA deg-
radation [2,3].
A plethora of studies have demonstrated that miRNAs and their
targets are aberrantly expressed in colon cancer [4–8]. For example,
expression of miR-21, miR-143 and miR-145 have been shown to be
differentially expressed in human colonic tumors as compared to
normal colon. These miRNAs have been shown to target several key
signal transduction pathways (e.g., Notch signaling) that directly
modulate malignant transformation and have been suggested to be
utilized as biomarkers for detection of colorectal cancer (CRC) [9–13].
For example, Iliopoulos et al. reported an inverse correlation between
miR-193a and K-RAS, one of the oncogenes commonly mutated in
CRC [14].
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ing the post-transcriptional genetic programming of stem and progeni-
tor cells [15]. A recent study systematically examinedmiRNA expression
proﬁles in adult tissue-speciﬁc stem cells and their differentiated coun-
terparts [16]. A common signature of miRNA expression in blood,
muscle and neural stem cell populations was detected. This suggests
that miRNA signatures mark the transition from self-renewing and
quiescent stem cells to proliferative and differentiating progenitor
cells, implying an extensive role of miRNAs in regulating self-renewal,
proliferation, and quiescence programs in the cells [17]. In recent
years, it has been suggested that intestinal tumors arise from a popula-
tion of ‘cancer stem cells (CSCs)’, which exhibit stem-like features
(e.g., self-renewal and pluripotency) and contribute to metastasis and
resistance to treatment [18,19]. In addition, changes in miRNA expres-
sion levels may contribute to the generation andmaintenance of cancer
stem cells. Emerging data support this hypothesis and suggest that
changes in speciﬁcmiRNAsmay be diagnostic indicators of cancer relat-
ed stemness [12,13]. Moreover, miRNA proﬁling in cancer stem cells
isolated from human colon cancer cell lines (e.g., HT-29) using the
CD133 surface marker revealed 11 overexpressed miRNAs and eight
underexpressed miRNAs such as miR-429, miR-155, and miR-320d,
some of whichmay be involved in the regulation of stem cell differenti-
ation [20]. With the identiﬁcation of Lgr5 as a marker of fast-cycling
intestinal stem cells, it is now possible to determine the role of miRNAs
in this important cell population [21].
Over several decades, there is substantial experimental, epidemiolog-
ical and clinical evidence indicating that ﬁsh oil containing diets, rich in
n− 3 polyunsaturated fatty acids (PUFAs), e.g., docosahexaenoic acid
(DHA) and eicosapentaenoic acid (EPA), are protective against colon tu-
morigenesis [22–25]. It is likely that EPA and DHA function throughmul-
tiple pathways to decrease colon cancer risk, including modulation of
cyclooxygenase (COX) activity, changes in cellular oxidative stress, mod-
iﬁcation of gene expression and alterations in membrane dynamics and
cellular surface receptor function [23]. Work from our laboratory has
demonstrated a role for n− 3 PUFA in increasing the level of oxidative
stress in colonocytes to activate apoptosis [26,27]. We have also demon-
strated fundamental differences in gene expression proﬁles in rats fed a
ﬁsh oil enriched diet compared to corn oil or olive oil enriched diets [28].
In addition, the chemoprotective effect of ﬁsh oil is enhanced when a
highly fermentable ﬁber (pectin), capable of elevating colonic luminal
butyrate levels, is added to the diet [29–32]. Recently, we examined
the effects of colon carcinogenesis on non-coding RNAs in a rat model
by cataloging mucosal miRNA expression following diet and carcinogen
exposure [33]. For this purpose, globalmiRNA and targetmRNA proﬁling
analyses were carried out. We demonstrated that the unique combina-
tion of chemoprotective dietary ﬁsh oil (containing EPA and DHA) and
pectin (fermented to butyrate in the large intestine) modulated a subset
of mucosal miRNAs-miR-19b, miR-26b andmiR-203 and their predicted
target genes — IGF1R, PTK2B, PDE4B and TCF4. Speciﬁcally, miR-19b,
miR-26b and miR-203 were signiﬁcantly down-regulated by the control
(corn oil and cellulose) diet in presence of carcinogen as compared to
ﬁsh oil pectin diet in the presence of carcinogen, whereas their predicted
targets PTK2B, IGF1R, PDE4B and TCF4 were inversely up-regulated.
Immunoblotting analyses further revealed that the targets were also
modulated at the protein level [34]. It is noteworthy that these diet-
modulatedmiRNAs are also aberrantly expressed in colon tumorigenesis
and other types of cancers [35]. Collectively, these data demonstrate that
the novel combination of ﬁsh oil/pectin protects the colon from
carcinogen-induced miRNA dysregulation [34]. However, to date, the
miRNA expression proﬁle in colon stem cells has not been documented,
nor has the effects of chemoprotective dietary components on colonic
stem cell non-coding miRNA signatures have not been determined.
Hence, with the identiﬁcation of Lgr5 as the ﬁrst deﬁnitive intestinal
stem cell marker in mice, we used the Lgr5-EGFP-IRES-cre ERT2 knock
inmouse model to visualize and isolate intestinal stem cells, establish
their stem cell-speciﬁc miRNA expression proﬁle, and examine theirresponse to chemotherapeutic agents by measuring miRNA expression.
This was contrasted with components of the stem cell “niche”
(i.e., daughter cells), which contribute to the physiological microenvi-
ronment consisting of specialized cells that physically anchor the stem
cell and provide the necessary factors tomaintain stemness.We hypoth-
esized that a chemoprotective diet containing n− 3 PUFA (ﬁsh oil) and
butyrate (pectin)wouldmodulate the stem cellmiRNAproﬁle. Our over-
all goal is to better understand how the colonic stem cell population re-
sponds to environmental factors such as diet and carcinogen. Hence, we
investigated the effects of disease progression onmiRNAs in colonic stem
cells by feedingmice injectedwith azoxymethane (AOM, a colon-speciﬁc
carcinogen) a diet containing n− 3 PUFA and a fermentable ﬁber (ﬁsh
oil + pectin) diet (FP) or n− 6 PUFA and a poorly fermentable ﬁber
(corn oil + cellulose) (CC).
For the purpose of validating the predicted miRNA:mRNA associa-
tions of miR-19b, 26b and 203 [34], we also conducted a series of loss
and gain of function analyses by knocking down or overexpressing se-
lectmiRNAs in human colon cancer cell line (HCT116). The global abun-
dance of protein levels in theHCT116modelwas subsequently assessed.
In addition, luciferase reporter assays were utilized and miRNA physio-
logical functionwas assessed by examining effects on apoptosis and cell
proliferation. Our results demonstrate that PDE4B and TCF4 are direct
targets of miR-26b and miR-203, respectively; while PTK2B is an indi-
rect target of miR-19b and that these important mediators exhibit
chemoprotective properties. The role of thesemiRNAs and their validat-
ed targets in intestinal stem cells was also investigated.
2. Materials and methods
2.1. Cell culture
HCT116 cells (p53+/+) were originally obtained from Dr. Bert
Vogelstein, Johns Hopkins University, Baltimore, MD [36]. These cells
were cultured in McCoy's 5A medium supplemented with 10% deﬁned
fetal bovine serum (Thermo Scientiﬁc, Wilmington, DE) and 2 mM
GlutaMAX (Gibco, Carlsbad, CA) at 37 °C in 5% CO2.
2.2. Transfection
Cells were seeded at 1–2 × 105 cells per well in a 12-well plate, and
upon reaching 70% conﬂuence were transfected with 5′ FITC-labeled
miRNA inhibitors (Exiqon, Denmark) anti-miR-19b, anti-miR-26b or
anti-miR-203 (30 nM) using Lipofectamine 2000 reagent (Invitrogen,
Carlsbad, CA). Scrambled miR was utilized as a negative control. Follow-
ing transfection (12 h), the media was changed and the efﬁciency was
assessed by imaging with a Zeiss 510 META NLO Multiphoton Micro-
scope System with an Axiovert 200 MOT microscope (Carl Zeiss
Microimaging, Thornwood, NY). For overexpression of miRNAs, cells
were transfected with miRNA mimics (30 nM) (Dharmacon, Lafayette,
CO) for miR-19b, miR-26b, miR-203 or scrambledmiR. Each experiment
was performed in triplicate. The sequences of the miRNA mimics, inhib-
itors and scrambled controls are described in Supplementary Table 1.
2.3. Total RNA isolation and Real Time PCR
Forty-eight hr. following transfection with miRNA inhibitors in
HCT116 cells, media was removed and cells were washed with phos-
phate buffered saline (PBS) (Gibco, Carlsbad, CA). RNA lysis buffer pro-
videdwithmiRVanamiRNA isolation kit (Ambion, Austin)was added to
eachwell andmonolayers were removed using a cell scraper. Total RNA
was isolated using the miRVana miRNA isolation kit as per the
manufacturer's protocol. RNA quantity and quality were measured
using a Nanodrop (Thermo Scientiﬁc, Wilmington, DE) and an Agilent
2100 Bioanalyzer (Agilent Technologies, CA), respectively. Real time
PCR was carried out using miRNA TaqMan PCR assays (Applied
Biosystems) to determine the expression of mature miR-19b, miR-26b
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ried out using the 2ΔΔCT method relative to 18S rRNA.
2.4. Western blotting
In order to determine the change in protein expression associated
with miRNA knockdown, Western blotting was carried out. Cells
(2–4 × 106) were seeded in 100 mm dishes on the day of transfection.
Transfection with miRNA inhibitors (30 nM) was carried out as
described above. Forty-eight hr. following transfection, media was
removed and cells were washedwith PBS. Subsequently, lysis buffer con-
taining 50 mM Tris–HCl (pH 7.2), 250 mM sucrose, 2 mM ethylenedi-
aminetetraacetic acid (pH 7.6), 1 mM ethyleneglycol-bis
(aminoethylether)-tetraacetic acid (pH 7.5), 50 μM NaF, 1% Triton-X,
100 μM sodium orthovanadate, protease inhibitor cocktail and 10 mM
β-mercaptoethanol was added to the cells. The lysate was then passed
through a 27 gauge needle and incubated on ice for 30min. Subsequently,
lysates were centrifuged at 16,000 g for 20 min. Supernatants were col-
lected and protein concentration determined by the Bradford method
[37]. Samples (20–80 μg) were loaded onto 4–20% Tris-Glycine gels
(Invitrogen, Carlsbad, CA). After blotting, membranes were incubated
overnight with rabbit polyclonal PDE4B antibody at 1:200 (Abcam,
Cambridge, MA), rabbit TCF4monoclonal antibody at 1:1000 (Cell signal-
ing Technology, Boston, MA) or rabbit PTK2B antibody at 1:1000 (Cell
Signaling Technology, Boston, MA) and horseradish peroxidase linked
(Jackson Immunoresearch Laboratories, West Groove, PA) secondary an-
tibody at 1:7000 dilution and chemoluminescent detection was per-
formed. Unless noted, all other reagents were from Sigma-Aldrich, MA.
2.5. Dual luciferase reporter assay
Cells were plated at 0.2 × 105 cells per well in a 96 well plate and
transfected using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) with
a reporter plasmid containing a Renilla luciferase coding region followed
by the 3′ UTR of PTK2B or PDE4B (Switchgear Genomics, Menlo Park,
CA) or dual luciferase reporter plasmid containingwild type ormutated
3′UTRof TCF4 (Genecopoeia, Rockville,MD). For PTK2B andPDE4B con-
structs, a ﬁreﬂy reporter plasmid was cotransfected for normalization
purposes. A control 3′ UTR plasmid with a random non-conserved and
non-repetitive 3′ UTR sequence (scrambled 3ʹUTR) was utilized as a
negative control for reporter plasmids. miR-19b, miR-26b, miR-203 or
scrambled controlled miRNA mimics (30 nM) were subsequently co-
transfected with cells according to the manufacturer's instructions.
Twenty-four hr. after transfection, dual luciferase reporter assays
(Promega) were performed according to the manufacturer's instruc-
tions. The Renilla luciferase activity was measured using a SpectraMax
L Luminescence Microplate Reader (Molecular Devices Sunnyvale, CA)
and normalized to the ﬁreﬂy luciferase activity. To assess the direct
binding of PDE4B with miR-26b, morpholinos (0.5 μM, classiﬁed as tar-
get protectors) (Gene Tools, Philomath, OR) against PDE4B were also
co-transfected along with a reporter plasmid containing 3′ UTR of
PDE4B. Results are presented as the average of three sets of replicates.
The sequences of themiRNA inhibitors, miRNAmimics and 3′ UTR con-
structs are described in Supplemental Table 1.
2.6. Animals
All procedures involving animals followed guidelines approved by
the Institutional Animal Care and Use Committee at Texas A&MUniver-
sity in accordance with EU Directive 2010/63/EU for animal experi-
ments. Lgr5-EGFP-IRES-creERT2 originally described by Barker et al.
(10–15 wk. of age) were used [21]. The study utilized two types of die-
tary fat and ﬁber –(control diet) corn oil (n− 6 PUFA)+ cellulose com-
pared to (chemoprotective diet) ﬁsh oil (n− 3 PUFA)+ pectin and two
injection treatments (colon carcinogen, AOM or saline). Animals (n= 5
per group) were terminated eight wks after the last AOM injection.Immediately after termination, 1 cm of distal colon was rapidly re-
moved, ﬂushed with ice-cold saline and immediately ﬁxed in 4% para-
formaldehyde for immunoﬂuorescence (IF) analyses. Supplemental
Figs. 1 and 2 show the timeline of the treatments and the experimental
design.2.7. Experimental diets
Lgr5-EGFP-IRES-creERT2 mice were assigned to one of the two diet
groups (ﬁsh oil/pectin or corn oil/cellulose), which differed only in the
type of fat and ﬁber. Diets contained (g/100 g diet): dextrose, 51.00;
casein, 22.40; D,L-methionine, 0.34; American Institute of Nutrition
(AIN)-76 salt mix, 3.91; AIN-76 vitamin mix, 1.12; choline chloride,
0.13; pectin or cellulose, 6.00. The total fat content of each diet
was 15% by weight with the n − 6 PUFA diet containing 15.0 g corn
oil/100 g diet (Dyets, Bethlehem, PA) and the n− 3 PUFA diet contain-
ing 11.5 g ﬁsh oil/100 g diet (Omega Protein, Houston, TX) plus 3.5 g
corn oil/100 g diet to prevent essential fatty acid deﬁciency. All diet in-
gredients except oils were obtained from Bio-serv (Frenchtown, NJ). To
prevent the formation of oxidized lipids, diets were stored at -20 °C and
provided fresh to animals every day.Fluorescence activated cell sorting of
colonic stem cells. Colonic crypts from individual mice were isolated as
previously described Sato et al. [38] withminor modiﬁcation. The intact
colons were everted on a disposable mouse gauge needle (Instech
Laboratories) and incubated with 20 mM EDTA in PBS at 37 °C for
30 min. Following transfer to chilled Ca/Mg free HBSS, colons were vig-
orously vortexed to release crypts. The cryptswere then incubatedwith
50 ul of DNase (stock concentration- 20 units/ml) in 10ml of trypsin so-
lution and single cells were then passed through a 40 μm cell strainer.
Cells were counted and resuspended to a ﬁnal cell density of 2 × 106
cells/mL. FACS (Fluorescence activated cell sorting) was then carried
out to isolate the Lgr5high expressing stem cells, Lgr5low expressing
daughter cells and Lgr5negative cells isolated from the colon using a BD
FACS Aria II cytometer/sorter (BD Biosciences). Cells from wild type
mice were used to set the gates for sorting (Supplemental Fig. 2).2.8. RNA analyses
Total RNA from Lgr5high, Lgr5low and Lgr5negative sorted cells was iso-
lated. For this purpose, cells from individual mice from all 4 groups
(total of 60 samples) were separately processed using the mirVana
miRNA Isolation Kit according to manufacturer's instructions (Ambion,
Austin, TX). Expression of 368 mature miRNAs was determined using
TaqMan Rodent MicroRNA A Array 2.0 (Life Technologies, Grand Island,
NY) as we have previously described [33,34]. For mRNA proﬁling, sam-
ples were randomized prior to RNASeq library preparation. Sequencing
libraries from RNA (10 ng) were generated using the TruSeq RNA
Sample Preparation kit (Illumina, San diego, CA). ERCC (Life Technolo-
gies, Grand Island, NY) was added at the appropriate level as per manu-
facturer instructions. The libraries were pooled and sequenced using an
Illumina HiSeq 2500 at SeqWright Genomic Services (Houston, TX).
Sequencing data was provided demultiplexed and aligned using STAR
with default parameters [39] and referenced against Mus musculus
(UCSC version mm10).2.9. In vivo apoptosis measurement
To investigate whether alkylating agent-induced DNA damage in-
duces apoptotic cell death in colonic epithelial cells, fragmented DNA
was visualized using the TACS 2 TdT-Fluor in situ apoptosis detection
kit (Trevigen) as per the manufacturer's recommended protocol for
staining. Negative control slides were incubated without TdT
enzyme.
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Images of colonic crypts were captured using an inverted TE 300
Nikon Eclipse ﬂuorescence microscope equipped with a Photometrics
Cool snap EZ cooled digital CCD camera. Images were processed using
NIS Image software, version3.2. A total of 68 (CCS, corn oil+cellulose+
saline), 75 (CCA, corn oil + cellulose + AOM), 51 (FPS, ﬁsh oil + pecti-
ne+ saline) and 141 (FPA, ﬁsh oil + pectine+AOM)GFP+ crypts from
5 mice were counted. All images were captured at a magniﬁcation of
40×.
2.11. High multiplicity ACF assay
To determine whether the chemoprotective (ﬁsh oil + pectin) diet
was able to suppress formation of early preneoplastic lesions of colon
cancer (aberrant crypt foci, ACF) compared with the control (corn
oil + cellulose) diet, we collected distal colon 8 wk. after the last AOM
injection. Colons were opened and placed ﬂat onto folded Whatman
#1 paper, followed by ﬁxation in 70% ethanol for 24 h. To identify aber-
rant crypts, tissue was stained in a 0.5% solution of methylene blue for
45 s. The total number of high multiplicity ACF (HM ACF) (foci contain-
ing 4 or more aberrant crypts) were counted using a 40× objective.
2.12. Statistical Analyses
For target validation experiments, the effect of more than two inde-
pendent variables (treatment effects) was assessed using the one-way
analysis of variance test (ANOVA), and differences among the means
were evaluated using Tukey's and Bonferroni post-hoc test of contrast.
P values b 0.05 were considered to be statistically signiﬁcant. Graphs
were plotted using means and standard errors of 6 to 8 cell culture
wells (data points) obtained from each treatment, collected from
three different experiments (performed in triplicate). Standard error
bars were plotted in order to document the variation in the population
mean. For miRNA and mRNA proﬁling, two sided t-tests with Welch
correction for unequal variancewere performed on selectmiRNA across
the speciﬁc treatment comparisons of interest. Mann–Whitney U non-
parametric tests were also performed as a control against non-normal
data and similar P-values were obtained. Standard error bars were
plotted in order to document the variation in the population mean. P
values b0.05 were considered to be statistically signiﬁcant, and genes
were selected for analysis using prior knowledge without considering
P-values. Therefore, no multiple testing correction procedure was
used. Standardized differences for the miRNAs and mRNAs were
computed and a two-sample t-test was utilized to compare them.
Small p-values indicated strong evidence of the hypothesized trend.
For phenotypic analyses, cells were plated at 0.2 × 105 cells per well
in 96 well plates and miRNA inhibitors or control treatments were
transfected as described above. Approximately 48 h later, apoptosis
was measured using a cellular fragmentation enzyme linked immune-
sorbent assay (ELISA) (Roche, IN). Floating cells were harvested,
washed, lysed and centrifuged to sediment nuclei. Supernatants con-
taining mono- and oligonucloesomes were incubated with substrate
and subsequently analyzed by ELISA as previously described [40]. To de-
termine the effect of treatment on cell proliferation, equal numbers of
cells were seeded in a 96 well plate and 48 h later, the number of cells
was counted using a hemocytometer. All experiments were performed
in triplicate.
3. Results
Since the unique combination of chemoprotective dietary ﬁsh oil
and pectin modulates a subset of mucosal miRNAs and their predicted
target genes in thepresenceof carcinogen [33,34],we further elucidated
the biological properties of miR-19b, miR-26b and miR-203 miRNAs
with respect to their target genes. In addition, the modulatoryproperties of diet with respect to miRNAs and their target genes in in-
testinal stem cells were investigated.
3.1. PTK2B is an indirect target of miR-19b
As shown in Supplemental Table 2, miR-19b, miR-26b and miR-203
share 100% homology between human (hsa), mouse (mmu) and rat
(rno). The sequences were obtained from the miRBase database
(www.mirbase.org/). To determine if PTK2B levels are modulated
following miR-19b knockdown, HCT116 cells were transfected with
anti-miR-19b inhibitor or with a scrambled miRNA inhibitor control
(negative control). The predicted pairing of the target 3′ UTR gene re-
gion with miR-19b is shown in Fig. 1A. With a transfection efﬁciency
of N70%, 48 h following knockdown, miR-19b levels were signiﬁcantly
decreased by ~90% as compared to scrambled control and non-
transfected control (Fig. 1B). Dose dependent knockdown of miR-19b
was carried out to determine the optimal concentration of miR-19b in-
hibitor (Supplemental Fig. 3). Correspondingly, PTK2B protein levels
were signiﬁcantly increased by approximately 200% in miR-19b knock-
down samples compared with negative control and non-transfected
control (Fig. 1C and D). Alternatively, HCT116 cells were transfected
withmiR-19bmimic or scrambledmiRmimic control and 48h later, ex-
pression of miR-19b was signiﬁcantly (P b 0.05) increased (Fig. 1E).
Dose dependent overexpression of miR-19b was initially carried out to
determine the optimal concentration of miR-19b mimic (Supplemental
Fig. 4). Following transfection, PTK2B protein levels were signiﬁcantly
(P b 0.05) decreased by approximately 60% in cells overexpressing
miR-19b compared to the negative control and non-transfected control
(Fig. 1F and G). These results indicate that PTK2B was signiﬁcantly
inhibited by miR-19b. In order to further determine if PTK2B is a direct
target of miR-19b, a 3′UTR reporter plasmid containing the predicted
miR-19b binding site of PTK2B (Figs. 1A and 2A) was utilized. HCT116
cells were co-transfected withmiR-19bmimic and 3′UTR PTK2B Renilla
reporter plasmid (PTK2B 3′ UTR) and the Renilla luciferase signal was
normalized to control-ﬁreﬂy activity (transfection control). Separately,
a control plasmid, containing a 3ʹUTR with a scrambled sequence
(scrambled 3′ UTR) that was non-conserved and non-repetitive, was
co-transfected with miR-19b mimic in HCT116 cells. This served as a
negative control. Twenty-four hr. later, luciferase activity was unaffect-
ed relative to the negative control (Fig. 2B). These data indicate that
PTK2B is not a direct target of miR-19b.
3.2. PDE4B is a direct target of miR-26b
To determine if PDE4B is directly targeted bymiR-26b, HCT116 cells
were transfectedwith an anti-miR-26b inhibitor orwith scrambled con-
trol miRNA inhibitor (negative control). Dose dependent knockdown of
miR-26b was carried out to determine the optimal concentration of
miR-26b inhibitor (Supplemental Fig. 5). Forty-eight hr. following
knockdown, miR-26b levels were signiﬁcantly decreased (P b 0.05) by
75% as compared to control (Fig. 3B), and correspondingly, PDE4B pro-
tein levels were signiﬁcantly (P b 0.05) increased by 100% in miR-26b
knockdown samples compared with negative control and non-
transfected control (Fig. 3C and D). In addition, in HCT116 cells
transfected with miR-26b mimic or scrambled miR mimic control for
48 h, miR-26b levels were signiﬁcantly (P b 0.05) increased (Fig. 3E)
and PDE4B protein levels were signiﬁcantly (P b 0.05) decreased by
55% in miR-26b overexpressed samples compared to the negative con-
trol and non-transfected control (Fig. 3F and G). Dose dependent over-
expression of miR-26b was initially carried out to determine the
optimal concentration of miR-26b mimic (Supplemental Fig. 6). These
results indicate that PDE4B is downregulated by miR-26b. In order to
determine if PDE4B is a direct target of miR-26b, a 3ʹUTR reporter plas-
mid containing the miRNA binding site of PDE4B (Figs. 3A and 4A)was
utilized. HCT116 cells were cotransfected with miR-26b mimic, 3ʹUTR
PDE4B Renilla reporter plasmid (PDE4B 3′ UTR) and a normalization
Fig. 1. PTK2B expression following knockdown or overexpression ofmiR-19b. (A) Predicted binding ofmiR-19b to the 3′UTR of PTK2B as assessed by Target Scan (http://www.targetscan.
org/). (B) Knockdown ofmiR-19bwas carried out by transfectingmiR-19b inhibitor or scrambledmiRNA inhibitor (control) inHCT116 cells. Forty-eight h following transfection,miR-19b
expression was measured by qRT-PCR. (C) PTK2B protein levels were measured byWestern blotting after miR-19b knockdown and β-actin was used as a loading control as described in
the Materials and Methods. (D) Quantiﬁcation of PTK2B levels in control (no transfection), scrambled control or miR-19b knockdown samples from immunoblot images.
(E) Overexpression of miR-19b was carried out by transfecting miR-19b mimic or scrambled miRNA mimic control and 24 h later, miR-19b expression was measured by qRT-PCR.
(F) PTK2B protein levels were measured byWestern blotting following miR-19b overexpression, and β-actin was used as a loading control. (G) Quantiﬁcation of PTK2B levels in control
(no transfection), scrambled control or miR-19b overexpressed samples from immunoblot images. Data represent means ± S.E. from six-eight replicate values obtained from three sep-
arate experiments. Signiﬁcant differences between groups are indicated as ***P b 0.001, and *P b 0.05.
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control 3′ UTR plasmid with a random sequence (scrambled 3ʹUTR) or
a non-conserved and non-repetitive 3′ UTR sequence were co-
transfected with miR-26b. Twenty-four hr. later, luciferase activity
was signiﬁcantly (P b 0.05) decreased by 50% relative to the negative
control (Fig. 4B). These data demonstrate that PDE4B is a direct target
of miR-26b. To further conﬁrm themiR-26b regulation on PDE4B, a tar-
get protection analysis was utilized. Predicted target sites on mRNAs
were protected by the complimentary binding of morpholinos, thereby
reducing miRNA suppression on luciferase activity [41]. HCT116 cells
were co-transfected with a morpholino targeting PDE4B mRNA,
PDE4B 3′ UTR Renilla reporter plasmid, a normalization control-ﬁreﬂy
reporter plasmid (transfection control) andmiR-26bmimic. Signiﬁcant-
ly increased luciferase activity (P b 0.05) was observed in HCT116 cells
co-transfected with morpholino compared to cells with no protective
oligos (Fig. 4B). Separately, as a negative control, PDE4B target protector
control was co-transfectedwith PDE4B 3′UTR plasmid. Themorpholino
masked the 3′ UTRmiRNA binding site, blocking the mimic, thereby in-
creasing luciferase expression. This conﬁrmed that PDE4B is a direct tar-
get of miR-26b.
3.3. TCF4 is a direct target of miR-203
To determine if TCF4 levels are modulated following miR-203
knockdown, HCT116 cells were transfectedwith anti-miR-203 inhibitoror with a scrambled control miRNA inhibitor (negative control). Dose
dependent knockdown ofmiR-203was carried out to determine the op-
timal concentration of miR-203 inhibitor (Supplemental Fig. 7). Forty-
eight hr. following knockdown, miR-203 levels were signiﬁcantly
(P b 0.05) decreased as compared to the controls (Fig. 5B). Correspond-
ingly, TCF4 protein levels were signiﬁcantly increased (P b 0.05) by an
average of 100% in miR-203 knockdown samples compared with the
negative control and non-transfected control (Fig. 5C and D). In com-
parison, in HCT116 cells transfected with miR-203 mimic or scrambled
miR mimic control, miR-203 levels were signiﬁcantly (P b 0.05) in-
creased (Fig. 5E). Dose dependent overexpression of miR-203 was ini-
tially carried out to determine the optimal concentration of miR-203
mimic (Supplemental Fig. 8). Correspondingly, TCF4 protein levels
were signiﬁcantly decreased (P b 0.05) by an average of 180% in miR-
203 overexpressed samples compared with negative control and non-
transfected control (Fig. 5F and G). These results indicate that TCF4 ex-
pression is inversely correlated withmiR-203 abundance. To determine
if TCF4 is a direct target ofmiR-203, a 3ʹUTR reporter plasmid containing
the miRNA binding site of TCF4 (Figs. 5A and 6A)was utilized. HCT116
cells were cotransfectedwithmiR-203mimic and the 3ʹUTR TCF4 Fireﬂy
reporter plasmid. In separate experiments, as a negative control, a
control 3′ UTR plasmid with a random sequence (scrambled 3ʹUTR)
was co-transfected with miR-203 mimic. Twenty-four hr. later, lucifer-
ase activity was signiﬁcantly decreased (P b 0.05) by ~120% relative to
the negative control. In order to conﬁrm this result, the binding sites
Fig. 2. Validation of PTK2B as a gene target of miR-19b. (A) Schematic representation of the 3ʹUTR PTK2B Renilla reporter plasmid, scrambled 3ʹUTR Renilla reporter plasmid and normal-
ization using a control-ﬁreﬂy reporter plasmid (transfection control). (B) Luciferase activity was determined 24 h following transfection. All luciferase values were normalized to ﬁreﬂy
luciferase (transfection control). Data represent means ± S.E. from nine replicate values obtained from three separate experiments. Signiﬁcant differences between groups are indicated
as *P b 0.05.
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the 3′ UTR of TCF4, i.e., “catttcaa”, was mutated to “gcgatatc” (Fig. 6B).
When a mutated 3′ UTR version of TCF4 was co-transfected with the
miR-203 mimic, there was no change in luciferase activity compared
to the miRNA target clone control vector (Fig. 6C), conﬁrming the spec-
iﬁcity of miR-203 binding. These ﬁndings demonstrate that TCF4 is a di-
rect target of miR-203.
3.4. miR-19b and miR-26b induce apoptosis whereas miR-203 reduces cell
proliferation
Studies have shown that dietary ﬁsh oil and pectin combination is
uniquely chemoprotective, in part, because it promotes apoptosis in
the colon [29,42]. We have previously demonstrated that the levels of
miR-26b and miR-203 were reduced by feeding the control diet
consisting of corn oil and cellulose (CCA) as compared to the
chemoprotective ﬁsh oil and pectin (FPA) combination diet, in the
presence of carcinogen [34]. Hence, in order to elucidate howalterations
inmiRNAs in the colon alter cell growth and viability, HCT116 cells were
transfectedwithmiR-19b, miR-26bmimic or scrambled control miRNA.
A 100% increase (P b 0.05) in apoptotic index was observed when miR-
19b andmiR-26bwere overexpressed compared to untreated control or
scrambled control (Fig. 7), whereas therewas amodest increase of ~40%
(P b 0.05) in apoptotic index and a signiﬁcant decrease in cell number
when miR-203 was overexpressed (Fig. 7). Cell proliferation was not
determined for miR-19b andmiR-26b since previous studies have dem-
onstrated that these miRNAs do not alter cell division [43,44].3.5. Effect of diet on aberrant crypt foci (ACF) formation in the colon
To determine the role of miR-19b, miR-26b and miR-203 in the
colonic stem cell niche and to identify a putative miRNA signature
in vivo, Lgr5-EGFP-IRES-creERT2 knock in mice were fed with either a
(control) corn oil + cellulose diet (CCA) or a (chemoprotective) ﬁsh
oil + pectin (FPA) diet in the presence of carcinogen. AOM injected
mice fed the CCA diet exhibited a greater number of ACF compared to
the FPA chemoprotective diet; [44.7 ± 6.6 versus 28.4 ± 3.6, P b 0.05]
and high multiplicity-ACF; [6.4 ± 0.9 versus 4.3 ± 0.8, P = 0.06]
(Supplemental Fig. 9).
3.6. Assessment of global miRNA expression in colon adult stem cells
To globally assess miRNA proﬁles in stem/progenitors cells, colonic
crypt cells isolated from carcinogen or saline (control) injected mice
were FACS sorted to obtain stem cells (Lgr5high), progenitor/daughter
cells (Lgr5low) and differentiated cells (Lgr5negative) (Supplemental
Fig. 2). Following global miRNA proﬁling, 103 mature miRNAs (critical
threshold (ct) b35) were detected in the two cell populations (n = 20
samples per cell type) (see Table 1 in ( [99])). Using pooled miRNA
data from all 4 groups (i.e., CCA, FPA, CCS and FPS), 26 miRNAs
(P b 0.05)were differentially expressed in Lgr5high as compared to Lgr5-
negative cells (see Table 2 in ( [99])). In addition, comparisons between
Lgr5high vs Lgr5negative, and Lgr5low vs Lgr5negative populations revealed
that seven miRNAs were commonly down-regulated and ten up-
regulated in both stem cells and daughter cells compared to
Fig. 3. PDE4B expression following knockdown or overexpression ofmiR-26b. (A) Predicted binding ofmiR-26b to the 3′UTR of PDE4B as assessed by Target Scan (http://www.targetscan.
org/). (B) Knockdown of miR-26b was carried out by transfecting HCT116 cells with miR-26b inhibitor or scrambled miRNA inhibitor (control) for 48 h. miR-26b expression was subse-
quently measured by qRT-PCR. (C) PDE4B protein levels were measured by Western blotting following miR-26b knockdown. β-actin was used as a loading control as described in the
Materials and Methods. (D) Quantiﬁcation of PDE4B protein levels in control (no transfection), scrambled control or miR-26b knockdown cultures from immunoblot images.
(E) Overexpression of miR-26b was carried out by transfecting miR-26b mimic or scrambled miRNA mimic control. 24 h post transfection, miR-26b expression was measured by qRT-
PCR. (F) PDE4B protein levelsweremeasured byWestern blotting followingmiR-26b overexpression and β-actinwas used as a loading control. (G) Quantiﬁcation of PDE4B protein levels
in control (no transfection), scrambled control or miR-26b overexpressed samples from immunoblot images. Data represent means ± S.E. from six-eight replicate values obtained from
three separate experiments. Signiﬁcant differences between groups are indicated as ***P b 0.001.
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their daughter cells exhibit a somewhat similar miRNA proﬁle. In
contrast, miRNA proﬁles in stem cells and differentiated cells were
quite distinct.
In order to determine if certain miRNAs are uniquely expressed
in stem cells, miRNA in stem cells (Lgr5high) and daughter
stem cells (Lgr5low) were compared. miR-125a-5p, miR-190b and
miR-191 were enriched in stem cells compared to daughter cells
(Fig. 8B). Interestingly, miR-125a-5p, miR-190b and miR-191
were also signiﬁcantly (P b 0.05) up-regulated in stem cells
compared to differentiated cells (see Table 2 in ( [99])). This
suggests that miR-125a-5p, miR-190b and miR-191 may be re-
quired by stem cells and their expression decreases as cells
differentiate.3.7. Carcinogen modulates stem cell miRNAs
To determine the effect of carcinogen on colonic stem cell
miRNA expression patterns, both Lgr5high and Lgr5negative sorted
cells in AOM and saline treated groups were compared. Interest-
ingly, distinct effects of carcinogen on miRNA expression in Lgr5-
high vs Lgr5negative cells were observed (see Table 3 in ( [99])).This suggests that stem cell miRNAs are uniquely modulated by
carcinogen.3.8. Diet modulates stem cell miRNAs following exposure to carcinogen
To determine the effects of dietary bioactives on miRNA, e.g., miR-
19b, miR-26b and miR-203, expression in stem cells and differentiated
cells, select colonocyte populations from carcinogen injected Lgr5-cre-
EGFP mice fed the CCA or FPA experimental diets were examined.
Analysis of FACS sorted stem cells revealed that twelve miRNAs were
differentially expressed (P ≤ 0.05), ten of which were up-regulated
and two miRNAs were down-regulated in Lgr5high sorted cells in CCA
vs FPA treatment (see Table 4A in ( [99])). These miRNAs were not al-
tered in Lgr5high cells in presence of saline (CCS vs FPS) (see Table 4B
in ( [99])). To our surprise, miR-19b,miR-26b andmiR-203were signif-
icantly up-regulated (P ≤ 0.05) in Lgr5high stem cells obtained from CCA
vs FPA. This was unexpected based on previous observations using a
mixed population of colonic mucosal cells from rats fed a similar diet
[34]. In addition, we noted that 5 miRNAs - miR-10a, miR-21, miR-
200a, miR-203 and miR-218 that were altered in Lgr5high cells as com-
pared to Lgr5negative cells (see Table 2 in ( [99])) were also modulated
by diet.
Fig. 4. Validation of PDE4B as a gene target for miR-26b. (A) Schematic representation of the 3ʹUTR PTK2B Renilla reporter plasmid, scrambled 3ʹUTR Renilla reporter plasmid and normal-
ization control-ﬁreﬂy reporter plasmid used in the study. (B) Luciferase activity was determined 24 h after transfection. All luciferase values were normalized to ﬁreﬂy luciferase
(transfection control). Data represent means ± S.E. from nine values obtained from three separate experiments. Signiﬁcant differences between groups are indicated as ***P b 0.001.
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carcinogen on differentiated cells (Lgr5neg), 6 miRNAs were
signiﬁcantly (P ≤ 0.05) altered (see Table 5 in ( [99])). Out of
these, miR-19a and miR-19b were signiﬁcantly (P ≤ 0.05) down-
regulated in CCA compared to FPA treatment groups.3.9. Diet modulates PTK2B expression in differentiated cells
To determine if the validated targets of miR-19b, miR-26b and miR-
203, i.e., PTK2B, PDE4B and TCF4 (Figs. 1, 3 & 5), respectively, were al-
tered in stem cells and differentiated cells in CCA and FPA groups, RNA
sequencingwas carried out on the same samples for whichmiRNA pro-
ﬁlingwas performed. As part of the initial characterization, we assessed
the expression of several stem cell makers and self-renewal genes in
Lgr5high, Lgr5low and Lgr5negative cells, including Lgr5 expression. The ex-
pression level of fast cycling stem cell markers (e.g., Lgr5, Ascl2, Olfm4,
Lrig1)was up-regulated in Lgr5high cells as compared to Lgr5negative cells
(Supplemental Fig. 10) similar to a previous report [45]. The expression
of PTK2B andmiR-19bwere reciprocally modulated in the bulk popula-
tion of differentiated cells (Lgr5negative) from CCA vs FPA fed animals
(Fig. 9A). A signiﬁcant (P b 0.002) negative correlation between miR-
19 and PTK2B in differentiated cells was detected using a linear regres-
sion model (Fig. 9D). This observation is consistent with the data re-
ported in Figs. 1&2. In contrast, the expression of PDE4B and TCF4,
direct targets of miR-26b and miR-203, respectively, was not altered
in the bulk population of differentiated cells from CCA vs FPA fed ani-
mals (Fig. 9B & C). Furthermore, to understand themechanism of action
of thesemiRNAs and their targets at the stem cell level, we examined at
the expression of PTK2B, PDE4B and TCF4, speciﬁcally in Lgr5high cells.To our surprise, the changes in the expression of the targets were not
as expected (i.e., decreased in CCA vs FPA treatment). In contrast,
there was no change in expression of PTK2B and TCF4 in CCA group as
compared to FPA group in Lgr5high cells (fold change =0.93, p-value
=0.320 and fold change=1.08, p-value=0.137, respectively). The ex-
pression of PDE4Bwas signiﬁcantly downregulated in CCA vs FPA group
in Lgr5high cells (fold change =1.48, p –value =0.010). These ﬁndings
suggest that stem cell responses to diet may be distinct from the bulk
cell population in the colon.
3.10. Fish oil and pectin alter the number of apoptotic stem cells in mouse
distal colon
Reduced apoptosis is a signiﬁcant risk factor for development of
colon cancer [46]. Hence,we determined the effects ofﬁsh oil and pectin
feeding on the number of apoptotic stem cells in the distal colon. As
shown in Fig. 10, a higher number of apoptotic stem cells per crypt col-
umnwas observed in saline-injected ﬁsh oil/pectin (FPS) fed animals as
determined by TUNEL assay. Interestingly, AOM exposure suppressed
the proapoptotic effect (FPA vs FPS) in Lgr5-positive stem cells.
4. Discussion
Wehave recently demonstrated that n− 3 PUFA uniquelymodulate
carcinogen-directed miRNA signatures in the colon [33]. In addition,
previous studies have shown that the bioactive compounds associated
with dietary ﬁsh oil (DHA and EPA) and fermentable ﬁber (butyrate)
synergize to protect against colon carcinogenesis, primarily by enhanc-
ing apoptosis [29,31,46–48]. With regard to dietary combination,
Fig. 5. TCF4 expression following knockdown or overexpression of miR-203. (A) Predicted binding of miR-203 to the 3′ UTR of TCF4. (B) Knockdown of miR-203 was carried out by
transfectingmiR-203 inhibitor or scrambledmiRNA inhibitor (control) inHCT116 cells. 48 h following transfection,miR-203 expressionwasmeasured by qRT-PCR. (C) TCF4 protein levels
were measured byWestern blotting after miR-203 knockdown and β-actin was used as a loading control as described in the Materials and Methods. (D) Quantiﬁcation of TCF4 levels in
control (no transfection), scrambled control ormiR-203 knockdown samples from immunoblot images. (E) Overexpression ofmiR-203was carried out by transfectingmiR-203mimic or
scrambledmiRNAmimic control.miR-203 expressionwasmeasured by qRT-PCR 24 h later. (F) TCF4 protein levelsweremeasured byWestern blotting aftermiR-203 overexpression and
β-actinwas used as a loading control. (G) Quantiﬁcation of TCF4 levels in control (no transfection), scrambled control or miR-203 overexpressed samples from immunoblot images. Data
represent means ± S.E. from six - eight replicate values obtained from three separate experiments. Signiﬁcant differences between groups are indicated as ***P b 0.001.
129M.S. Shah et al. / Biochimica et Biophysica Acta 1862 (2016) 121–134i.e., fat ×ﬁber interaction in the presence of carcinogen (CCA vs FPA),we
observed a coherent relationship between miR-19b, miR-26b, miR-203
and PTK2B, PDE4B and TCF4, respectively [34]. These analyseswere per-
formed using a heterogeneous population of crypt cells. Since these
diet/carcinogen modulated-miRNAs may exhibit distinct functions in
different cell types, their role in colonic epithelial stemcellswarrants in-
vestigation. Therefore, to further elucidate the biological effects of diet
and carcinogen onmiRNAs and their targets in stem versus differentiat-
ed cell populations in the intestinal crypt, an integrated targeted ap-
proach was used.
We initially investigated the role of threemiRNAs previously shown
to be selectively modulated by bioactive n− 3 PUFA in combination
with fermentable ﬁber and carcinogen. By manipulating miRNA levels
and performing luciferase reporter assays, we demonstrated that
PDE4B and TCF4 are direct targets of miR-26b andmiR-203, respective-
ly. Even though PTK2Bprotein levelsweremodulated bymiR-19b, there
was no change in luciferase reporter activity, indicating the absence of
direct binding between miR19b and PTK2B. These data suggest that
miR-19b modulates PTK2B upstream target(s).
We have previously documented the ability of dietary ﬁsh oil/
pectin combination to increase miR-26b expression in the colon
[34]. This is noteworthy, because the suppression of miR-26b expres-
sion has been reported in various cancers including colon cancer, he-
patocellular carcinoma, breast cancer and prostate cancer [49–51]. Inaddition, miR-26b status has been associated with the invasiveness
and metastasis of colorectal cancer cells [49]. PDE4B (cAMP-speciﬁc
3′,5′-cyclic phosphodiesterase 4B) acts as an oncogene in colorectal
and other cancers [52] by limiting cAMP-associated apoptosis [53,
54]. In the present study, we observed that apoptosis was induced
with increasing levels of miR-26b (Fig. 7), which is consistent with
published reports [49–51]. In addition, previous studies from our
laboratory have shown that ﬁsh oil - pectin combination act syner-
gistically to induce apoptosis, both in vivo and in vitro, by recruiting
a p53 independent, oxidation sensitive, Ca2+ − mediated intrinsic
mitochondrial pathway [29,55]. Based on this evidence, we propose
a putative mechanism describing miR-26 action in the colon
(Supplemental Figure 11). By increasing mucosal levels of miR-
26b, ﬁsh oil-pectin combination decreases PDE4B expression,
which promotes cyclic adenosine monophosphate (cAMP) forma-
tion [56]. This can lead to reduction of phosphorylation at threonine
308 and serine 473 of Akt (i.e. pAKT) [57] and activation of protein
kinase A (PKA) [56]. From a chemoprotective standpoint, PKA can
promote apoptosis [58]. Moreover, decreased pAKT activity can re-
sult in a reduction in PIP3 levels and decrease the lipid kinase activity
of PI3K [57]. Interestingly, we have observed that other dietary
chemoprotective agents, e.g., curcumin, are capable of blocking in-
testinal dextran sodium sulfate-induced increase in PDE4B [59]. In
addition, EZH2, one of the targets of miR-26b, is modulated by
Fig. 6. Validation of TCF4 as a target gene for miR-203. (A) Schematic representation of the 3ʹUTR TCF4 Renilla reporter plasmid, scrambled 3′ UTR Renilla reporter plasmid and 3ʹUTRmu-
tant TCF4 Renilla reporter plasmid. (B) Schematic representation of 3′ UTR of TCF4 showing the putative miR-203 target site. Letters highlighted in red indicate the mutated base pairs.
(C) Luciferase activity was determined 24 h after transfection. All luciferase values were normalized to Renilla luciferase. Data represent means ± S.E. from nine values obtained from
three separate experiments. Signiﬁcant differences between groups are indicated as ***P b 0.001, **P b 0.01.
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and its targets may be modulated by chemoprotective bioactive die-
tary agents. Collectively, these ﬁndings suggest that miR-26b acts as
a “tumor suppressor” by targeting PDE4B and other genes.
The increased expression of miR-203 in HCT116 cells was associated
with decreased levels of one of its predicted targets, TCF4 (Fig. 5). miR-
203 is down-regulated in a number of cancers and was up-regulated in
the colonic mucosa of rats fed a ﬁsh oil - pectin combination diet [34,
61–66]. miR-203 down-regulation appears to bemediated by epigenet-
ic silencing. For example, studies in breast cancer andmultiplemyeloma
cells have shown that the miR-203 promoter is hypermethylated [61,
67]. Moreover, Lena et al. demonstrated that miR-203 is down-
regulated during epithelial commitment of embryonic stem cells [63].
Through overexpression or knockdown of miR-203 levels in HCT116
cells, we showed that TCF4 expression was inversely correlated to the
level of miR-203. Also, luciferase reporter assays showed that miR-203
directly binds to TCF4 and mutation of the miR-203 binding site in the
TCF4 3′ UTR abolished the effect of miR-203 (Fig. 4). These ﬁndings
are noteworthy because TCF4 is a well-known transcription factor
expressed in the intervillus pocket of the developing intestine and is re-
quired to establish proliferative progenitor cells of prospective crypts in
the embryonic intestine [68]. TCF4 is regulated by the Wnt signaling
pathway and controls stem cell fate in the intestine [69]. Indeed, it is
well appreciated that an increase in TCF4 levels promotes TCF4-β-
catenin interaction, which can lead to the inappropriate activation of a
TCF4 target gene program [70]. Previously, we have demonstrated
that colonic-β-catenin signaling, an upstream mediator of TCF4, is sup-
pressed in carcinogen injected rats fed a ﬁsh oil + pectin (FPA) as com-
pared to control diet (CCA) [42]. Based on our ﬁndings, we propose a
pathway by which CCA combination enhances hypermethylation ofthe miR-203 promoter, resulting in the reduced expression of mature
miR-203 (Supplemental Figure 12). Hence, TCF4 protein levels would
increase, thus promoting cell proliferation. Further work is needed in
order to determine how FPA modulates the expression of mature miR-
203 in the colon.
Recent ﬁndings lend support to the concept that in some circum-
stances, carcinogen exposure can perturb homeostasis within the
stem cell compartment and promote malignant transformation [71].
“Adult” somatic stem cells of the colon are of particular interest because
they sustain self-renewal capacity and are targets for cancer initiating
mutations [72–74]. Lgr5 is regarded as a speciﬁc marker for identiﬁca-
tion of intestinal stem cells [21]. Therefore, it is important to know
precisely how intestinal stem cell populations respond to environmen-
tal factors, speciﬁcally bioactive dietary agents. To date, the effect of a
chemoprotective n − 3 PUFA/pectin diet on miRNAs including miR-
19b, miR-26b and miR-203 in stem cells during initiation of colon
cancer has not been documented. Hence, in this study, we used the
Lgr5-EGFP-IRES-creERT2 knock in mouse model to examine miRNA
expression proﬁles in stem and differentiated cell populations. More-
over, since transformation of adult stem cells is an extremely efﬁcient
route towards initiation of intestinal cancer [74], Lgr5-EGFP-IRES-
creERT2 knock in mice were injected with AOM, a colon carcinogen.
The AOM-induced colon tumor model was selected because it provides
a clear distinction between tumor initiation and promotion [75].Wehy-
pothesized that the miRNA expression proﬁles would differ between
stem cells and differentiated cells. Of the 384 rodent miRNAs identiﬁed,
26 miRNAs in stem cells were signiﬁcantly altered compared to differ-
entiated cells (see Table 2 in ( [99])). We noted that select miRNAs,
e.g., miR-203, miR-145, miR-27a, miR-215, had a reduced expression
in Lgr5high cells as compared to Lgr5negative cells. These miRNAs were
Fig. 7. Effects ofmiR-19b,miR-26b andmiR-203 on colonocyte phenotype. (A) HCT116 cells were transfectedwithmiR-19b,miR-26b,miR-203 (30 nM) or scrambled controlmimic. After
72 h, the apoptosis index was measured. (B) HCT116 cells were transfected with either miR-203 mimic or scrambled control mimic for 72 h and total cell number was counted. Data
represent means ± S.E. from six culture wells obtained from two separate experiments. Signiﬁcant differences between groups are indicated as ***P b 0.001, **P b 0.01.
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cells [76–79]. Notch signaling has been shown to be important for Lgr5-
high stem cells [80] and in our data, Hes-1, a component of Notch signal-
ingwas upregulated in Lgr5high cells (Supplemental Fig. 10). miR-200b,
a target of Notch signaling [81], was also downregulated in stem cells. In
addition, several members of miR-17-92 clusters such as miR-17, miR-
92a and miR-20b were upregulated in stem cells as compared to differ-
entiated cells. It has been shown that this miRNA cluster is also highly
expressed in embryonic stem cells and plays a role in cell proliferation
[82,83]. Also, several miRNAs such as miR-10a, miR-155 and miR-191
have been shown to be important for self-renewal of hematopoietic
stem cells [84–87].
To determine stem cell speciﬁc miRNAs, we compared Lgr5high vs
Lgr5low daughter cells. Interestingly, three miRNAs, miR-125a-5p,
miR-190 and miR-191 exhibited signiﬁcantly (P b 0.05) higher levels
in the stem cells compared to daughter cells and differentiated cells
(Fig. 8B). These miRNAs were not differentially expressed in daughter
stem cells compared with differentiated cells, suggesting that they
might serve a speciﬁc role in intestinal stem cells. Speciﬁcally, miR-
125 has been shown to be reported to play an important role in normal
cell homeostasis in different tissues [88]. Higher levels of miR-125 have
been associated with hematopoietic and embryonic stem cells [89].
Concurrently, some of the validated targets of miR-125 such as Mcl-1,
TNFA1P3, Tp53inp1 and Orp9 were also signiﬁcantly downregulated
in Lgr5high stem cells (Supplemental Table 3-A).
Next, we wanted to identify miRNAs that were altered by AOM in
Lgr5high and Lgr5negative cells (see Table 3 in ( [99])). We observed that
miR-92a, a well-characterized oncomiR in colorectal cancer [90–94]was upregulated in stem cells, while miR-124 a tumor suppressor in co-
lorectal cancer was downregulated in stem cells as compared to differ-
entiated cells [95–97]. Interestingly, other members of miR-17-92,
e.g., miR-18a and miR-20b, were also upregulated in AOM-Lgr5negative
cells. This suggests that the miR-17-92 family is modulated by carcino-
gen in both stem cells and differentiated cells. In addition, expression of
miR-193b and miR-224 were also altered in differentiated cells as
shown previously in colorectal cancer [13,98].
Another interesting outcome of the study was that dietary bioactive
agents differentially modulated miRNAs based on their location in the
colonic crypt. In stem cells, miR-19b, miR-27b, miR-26b and miR-203
were up-regulated by CCA compared to FPA. However, in differentiated
cells, let-7a, let-7e and miR-19b were signiﬁcantly down-regulated
(P b 0.05) in CCA fed mice, similar to our previous study in which
scraped mucosa containing a heterogeneous population of cells from
the rat colon was assayed [34]. In order to elucidate the role of miRNAs
in stem cells, it is necessary to determine the function of these miRNAs
by identifying their targets. This was determined by performing global
mRNA proﬁling by RNA sequencing from the same samples that were
used to assess miRNA expression patterns. Importantly, we observed a
down-regulation ofmiR-19b andup-regulation of PTK2B in differentiat-
ed cells, which is consistent with our previous study [34], in which
scraped mucosa predominantly containing differentiated cells was
used.
We also observed that the increase in apoptosis in FPA compared to
CCA treatment in our previous studies [31] was not seen in stem cells.
This along with the fact that no change was observed in PDE4B or
PTK2B in the stem cells suggests that the function of miR-19b, miR-
Fig. 8. Expression of miRNAs in Lgr5high, Lgr5low and Lgr5negative populations. (A) Common differentially expressed miRNAs in Lgr5high and Lgr5low cells. The Venn diagram indicates the
number of differentially expressedmiRNAs in Lgr5high vs. Lgr5negative cells and Lgr5low vs. Lgr5negative cells (n=20mice per cell type). (B)miR-125a-5p,miR-190b andmiR-191 are speciﬁc
miRNAs enriched in intestinal stem cells. Data represent normalized miRNA expression (means ± SEM, for details, see Materials and methods). miRNA proﬁling in stem cells (Lgr5high-
black bar), daughter cells (Lgr5low- gray bar) and differentiated cells (Lgr5negative- white bar) by real time PCR was used to quantify miR-125a-5p, miR-190b and miR-191 expression
(pooled data). *P b 0.05. (n = 20 per cell type). mmu, mouse; rno, rat.
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teresting observation was that corn oil/cellulose vs ﬁsh oil/pectin feed-
ing reduced miR-125a-5p expression (see Table 4B in ( [99])) and
increased its putative gene targets, Mcl-1, Bcl-w, ARID3B, IGF2, and
IL6R, in Lgr5high cells (Supplemental Table 3-B). This is noteworthy, be-
cause these genes are generally considered to drive an anti-apoptoticFig. 9. Expression ofmiRNA and their targets in Lgr5negative cells sorted cells from CCA and FPA s
from CCA and FPA treated mice and expression of (A) miR-19b and PTK2B, (B) miR-26b and P
analysis was performed to determine the signiﬁcant negative correlation between miRNAs andphenotype [88]. Collectively, these data suggest that diet-modulated
miR-125a-5p may be necessary for stem cell maintenance. Hence, a
comprehensive analysis and identiﬁcation of additional downstream
targets of miR-125a-5p warrants further investigation.
In summary, our data indicate for the ﬁrst time that colonic stem cells
exhibit a unique miRNA signature. In addition, the chemoprotectiveamples. miRNA proﬁling and RNA sequencingwas performed using Lgr5negative cells sorted
DE4B and (C) miR-203 and TCF4 was determined, n = 5 per group. (D) Linear regression
their putative targets.
Fig. 10. Effect of diet on stem cell apoptosis. Saline injected ﬁsh oil/pectin fed mice exhib-
ited higher levels of apoptosis in stem cells. Bars with different letters are signiﬁcantly dif-
ferent (P b 0.05 by one tail test with Mixed Procedure and GENMOD Procedure).
133M.S. Shah et al. / Biochimica et Biophysica Acta 1862 (2016) 121–134effect of combined ﬁsh oil and pectin feeding, which antagonizes the on-
cogenic effects of carcinogen, modulated the expression of select
miRNAs. To our knowledge, this is theﬁrst study to utilize Lgr5+ reporter
mice to determine the impact of diet and carcinogen on miRNA expres-
sion in intestinal stem cells. The effect of the highly chemoprotective
ﬁsh oil + pectin combination on miRNA expression and their targets
on mucosal physiology is summarized in Supplemental Fig. 13.
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